Teriparatide therapy for severe, refractory osteoradionecrosis of the jaw
Sign Up to like & getrecommendations! Published in 2017 at "Osteoporosis International"
DOI: 10.1007/s00198-017-4343-2
Abstract: Although osteoradionecrosis (ORN) is a serious complication of craniofacial radiotherapy, the current management methods remain suboptimal. Teriparatide (TPTD), a recombinant human parathyroid hormone (1–34), has shown beneficial effects on osseous regeneration in medication-related osteonecrosis of… read more here.
Keywords: teriparatide therapy; tptd therapy; therapy; refractory ... See more keywords
A brief review and clinical evidences of teriparatide therapy for atypical femoral fractures associated with long-term bisphosphonate treatment
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Surgery"
DOI: 10.3389/fsurg.2022.1063170
Abstract: The risk of bisphosphonate (BP)-associated atypical femur fracture (AFF) has markedly increased over recent decades due to suppression of bone turnover, accumulation of structural micro-damage and reduction of bone remodeling consequent to long-term BP treatment.… read more here.
Keywords: teriparatide therapy; long term; bone; treatment ... See more keywords